Zavorotinskaya T - Search Results

1

Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13.

Zavorotinskaya T, Tomkinson A, Murphy JE. Zavorotinskaya T, et al. Mol Ther. 2003 Feb;7(2):155-62. doi: 10.1016/s1525-0016(02)00050-3. Mol Ther. 2003. PMID: 12597903 Free article.

2

Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.

Zavorotinskaya T, Albritton LM. Zavorotinskaya T, et al. Mol Ther. 2001 Mar;3(3):323-8. doi: 10.1006/mthe.2001.0262. Mol Ther. 2001. PMID: 11273774 Free article.

3

A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion.

Zavorotinskaya T, Qian Z, Franks J, Albritton LM. Zavorotinskaya T, et al. J Virol. 2004 Jan;78(1):473-81. doi: 10.1128/jvi.78.1.473-481.2004. J Virol. 2004. PMID: 14671127 Free PMC article.

4

The block to membrane fusion differs with the site of ligand insertion in modified retroviral envelope proteins.

Ryu BY, Zavorotinskaya T, Trentin B, Albritton LM. Ryu BY, et al. Among authors: zavorotinskaya t. J Gen Virol. 2008 Apr;89(Pt 4):1049-1058. doi: 10.1099/vir.0.83445-0. J Gen Virol. 2008. PMID: 18343849

5

Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein.

Zavorotinskaya T, Albritton LM. Zavorotinskaya T, et al. J Virol. 1999 Jun;73(6):5034-42. doi: 10.1128/JVI.73.6.5034-5042.1999. J Virol. 1999. PMID: 10233966 Free PMC article.

6

Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.

Zavorotinskaya T, Albritton LM. Zavorotinskaya T, et al. J Virol. 1999 Jul;73(7):5621-9. doi: 10.1128/JVI.73.7.5621-5629.1999. J Virol. 1999. PMID: 10364311 Free PMC article.

7

A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor.

Zavorotinskaya T, Albritton LM. Zavorotinskaya T, et al. J Virol. 1999 Dec;73(12):10164-72. doi: 10.1128/JVI.73.12.10164-10172.1999. J Virol. 1999. PMID: 10559332 Free PMC article.

8

Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry.

Malhotra S, Scott AG, Zavorotinskaya T, Albritton LM. Malhotra S, et al. Among authors: zavorotinskaya t. J Virol. 1996 Jan;70(1):321-6. doi: 10.1128/JVI.70.1.321-326.1996. J Virol. 1996. PMID: 8523543 Free PMC article.

9

A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.

Ray A, Du T, Wan X, Song Y, Pillai SC, Musa MA, Fang T, Moore J, Blank B, Du X, Chen X, Warne R, Sutimantanapi D, Lui F, Zavorotinskaya T, Colas C, Friedman L, Junttila MR, Chauhan D, Anderson KC. Ray A, et al. Among authors: zavorotinskaya t. Blood Cancer J. 2024 Apr 9;14(1):58. doi: 10.1038/s41408-024-01019-5. Blood Cancer J. 2024. PMID: 38594241 Free PMC article.

10

RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation.

Crowe MS, Zavorotinskaya T, Voliva CF, Shirley MD, Wang Y, Ruddy DA, Rakiec DP, Engelman JA, Stuart DD, Freeman AK. Crowe MS, et al. Among authors: zavorotinskaya t. Mol Cancer Res. 2021 Jun;19(6):1063-1075. doi: 10.1158/1541-7786.MCR-20-1022. Epub 2021 Mar 11. Mol Cancer Res. 2021. PMID: 33707308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters